PureTech Health plc (LON:PRTC)’s share price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 357.70 ($4.67) and traded as low as GBX 330 ($4.31). PureTech Health shares last traded at GBX 333.50 ($4.36), with a volume of 199,713 shares traded.
A number of equities analysts recently commented on the company. Peel Hunt reiterated a “buy” rating and set a GBX 930 ($12.15) price target on shares of PureTech Health in a report on Thursday, May 27th. Peel Hunt reiterated a “buy” rating and issued a GBX 930 ($12.15) price objective on shares of PureTech Health in a report on Thursday, May 27th. Finally, Liberum Capital reiterated a “buy” rating and issued a GBX 550 ($7.19) price objective on shares of PureTech Health in a report on Thursday, April 15th.
The stock has a market cap of £955.58 million and a P/E ratio of 222.33. The company has a current ratio of 2.29, a quick ratio of 2.25 and a debt-to-equity ratio of 11.72. The company has a 50 day moving average of GBX 357.70.
PureTech Health Company Profile (LON:PRTC)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Recommended Story: Do equity income investments outperform growth and income investments?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.